John McQueen

Association analyses identify 31 new risk loci for colorectal cancer susceptibility

Philip Law, Maria Timofeeva, Ceres Fernández–Rozadilla et al. · Nature Communications · 2019 · 265 citations · Full text

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Timothy Iveson, Rachel Kerr, Mark Saunders et al. · The Lancet Oncology · 2018 · 183 citations · Full text

Endometrial Histology and Biochemistry in Climacteric Women during Oestrogen and Oestrogen/Progestogen Therapy

Malcolm Whitehead, John McQueen, R.J.B. King et al. · Journal of the Royal Society of Medicine · 1979 · 130 citations · Full text

Fertility, Endometriosis, Endometrial Histology +24

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano et al. · The Lancet Oncology · 2024 · 89 citations

Gynecological Surgery, Medicine, Metronomic Therapy +6

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma

Philip Smith, Thomas Bradley, Lena Morrill Gavarró et al. · Nature Communications · 2023 · 51 citations · Full text